Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Zhangfan Ding, Jiayuan Zhang, Hanyu Liu, Abhishek Chandra, Makarand V. Risbud, Anjali P. Kusumbe
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials
2023
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
10.1038/s41408-024-01046-2 · 2024
Multidisciplinary approach for medication-related osteonecrosis of the jaws: a case report and literature review
10.7181/acfs.2024.0091 · 2025
Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: A systematic review
10.1111/odi.14003 · 2023
Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors
10.3390/jcm12083025 · 2023
Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options
10.3390/ijms25158053 · 2024
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
10.1002/ijc.35278 · 2025
Longitudinal evaluation of health-related quality of life after osteoradionecrosis of the mandible
10.1016/j.bjoms.2015.07.008 · 2015
doaj
Confidence 92%
datacite
Confidence 0%
The incidence of osteoradionecrosis of the jaws in oral cavity cancer patients treated with intensity-modulated radiotherapy: a systematic review and meta-analysis
10.1016/j.oooo.2024.04.008 · 2024
Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper
10.14219/jada.archive.2005.0108 · 2005
Dose translation from animal to human studies revisited
10.1096/fj.07-9574lsf · 2008
Bisphosphonate actions: physical chemistry revisited
10.1016/j.bone.2006.01.141 · 2006
Preclinical models of medication-related osteonecrosis of the jaw (MRONJ)
2021
The effects of Zoledronate administration routes on the reproducibility of BRONJ in rodent models: A systematic review
10.1016/j.bone.2025.117563 · 2025
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
10.1038/nature13145 · 2014
Lymphatic vessels in bone support regeneration after injury
10.1016/j.cell.2022.12.031 · 2023
PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis
10.1038/nm.3668 · 2014
Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model)
2023
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update
10.1016/j.joms.2022.02.008 · 2022
ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium
10.3390/oral5020025 · 2025
Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
10.1038/s41368-022-00182-4 · 2022
An evidence-guided review of preclinical strategies to counteract medication-related osteonecrosis of the jaw. What do rodent studies tell us?
10.1093/jbmrpl/ziaf182 · 2026
No additional external references are available.